Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001213900-14-002304
Filing Date
2014-04-10
Accepted
2014-04-10 16:48:06
Documents
5
Period of Report
2013-12-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT TO ANNUAL REPORT f10k2013a1_actiniumpharma.htm 10-K/A 44489
2 CERTIFICATION f10k2013a1ex31i_actinium.htm EX-31.1 10116
3 CERTIFICATION f10k2013a1ex31ii_actinium.htm EX-31.2 10221
4 CERTIFICATION f10k2013a1ex32i_actinium.htm EX-32.1 5471
5 CERTIFICATION f10k2013a1ex32ii_actinium.htm EX-32.2 5482
  Complete submission text file 0001213900-14-002304.txt   76861
Mailing Address 501 FIFTH AVENUE, 3RD FLOOR NEW YORK NY 10017
Business Address 501 FIFTH AVENUE, 3RD FLOOR NEW YORK NY 10017 212-300-2131
Actinium Pharmaceuticals, Inc. (Filer) CIK: 0001388320 (see all company filings)

EIN.: 880378336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-36374 | Film No.: 14757652
SIC: 6770 Blank Checks